
S03 E16: Pharma review of the year 2022
EMJ GOLD: Pharma news, views and analysis
00:00
The Rise of Medical Affairs
Investment in medical affairs rose to new levels over the last 12 months. Almost every company I talk to plans to have medical take on a more active and leading role in HCP engagement, he adds. He also believes they are still suffering from a confidence and identity crisis. And hopefully this change will be seen in 2023 and beyond.
Play episode from 16:39
Transcript


